Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
578
mi
from 98109
Reno, NV
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Washoe Cancer Services at Washoe Medical Center - Reno
578
mi
from 98109
Reno, NV
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2392
mi
from 98109
Lebanon, NH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2386
mi
from 98109
Marlton, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Fox Chase Virtua Health Cancer Program - Marlton
2386
mi
from 98109
Marlton, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2415
mi
from 98109
Toms River, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Regional Cancer Center at Community Medical Center
2415
mi
from 98109
Toms River, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2110
mi
from 98109
Buffalo, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Roswell Park Cancer Institute
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2414
mi
from 98109
Manhasset, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - North Shore University Hospital
2414
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2042
mi
from 98109
Akron, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Akron City Hospital
2042
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2078
mi
from 98109
Salem, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
2078
mi
from 98109
Salem, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2030
mi
from 98109
Wooster, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Treatment Center
2030
mi
from 98109
Wooster, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
1560
mi
from 98109
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LaFortune Cancer Center at St. John Medical Center
1560
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
1564
mi
from 98109
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
1564
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2363
mi
from 98109
Bryn Mawr, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Bryn Mawr Hospital
2363
mi
from 98109
Bryn Mawr, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2355
mi
from 98109
Paoli, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Paoli Memorial Hospital
2355
mi
from 98109
Paoli, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2371
mi
from 98109
Philadelphia, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Albert Einstein Cancer Center
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2366
mi
from 98109
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - MainLine Health
2366
mi
from 98109
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2366
mi
from 98109
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Lankenau Cancer Center at Lankenau Hospital
2366
mi
from 98109
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
699
mi
from 98109
Salt Lake City, UT
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LDS Hospital
699
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
2429
mi
from 98109
Portsmouth, VA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Naval Medical Center - Portsmouth
2429
mi
from 98109
Portsmouth, VA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
1512
mi
from 98109
La Crosse, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
1512
mi
from 98109
La Crosse, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
mi
from 98109
Menomonee Falls, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Memorial Hospital
mi
from 98109
Menomonee Falls, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
1681
mi
from 98109
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Medical College of Wisconsin Cancer Center
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
1684
mi
from 98109
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Veterans Affairs Medical Center - Milwaukee (Zablocki)
1684
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated:  11/16/2015
704
mi
from 98109
Palo Alto, CA
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated: 11/16/2015
Stanford/VA Palo Alto Mood Disorder Research Program
704
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2422
mi
from 98109
Charleston, SC
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
0
mi
from 98109
Seattle, WA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
959
mi
from 98109
Duarte, CA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
City of Hope National Medical Center
959
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2451
mi
from 98109
Gainesville, FL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University of Florida College of Medicine
2451
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2522
mi
from 98109
Tampa, FL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
H. Lee Moffitt Cancer Center
2522
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2178
mi
from 98109
Atlanta, GA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2174
mi
from 98109
Atlanta, GA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Blood and Marrow Transplant Program at Northside Hospital
2174
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1730
mi
from 98109
Chicago, IL
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1922
mi
from 98109
Ann Arbor, MI
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University of Michigan Medical Center
1922
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1932
mi
from 98109
Detroit, MI
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Karmanos Cancer Institute
1932
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1393
mi
from 98109
Minneapolis, MN
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1718
mi
from 98109
St. Louis, MO
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Washington University/Barnes Jewish Hospital
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1366
mi
from 98109
Omaha, NE
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Univ of Nebraska Med Ctr
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2402
mi
from 98109
New York, NY
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2024
mi
from 98109
Cleveland, OH
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
University Hospitals of Cleveland/Case Western
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
147
mi
from 98109
Portland, OR
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2373
mi
from 98109
Philadelphia, PA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Fox Chase, Temple University
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
1890
mi
from 98109
Houston, TX
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Baylor College of Medicine/The Methodist Hospital
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated:  11/16/2015
2352
mi
from 98109
Richmond, VA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (BMT CTN #0902)
Status: Enrolling
Updated: 11/16/2015
Virginia Commonwealth University, MCV Hospital
2352
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Progesterone for the Treatment of Cocaine Dependence - 1
Interactions Between Progesterone and Cocaine in Women
Status: Enrolling
Updated:  11/16/2015
1393
mi
from 98109
Minneapolis, MN
Progesterone for the Treatment of Cocaine Dependence - 1
Interactions Between Progesterone and Cocaine in Women
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
2244
mi
from 98109
Dothan, AL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
2244
mi
from 98109
Dothan, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
962
mi
from 98109
Los Angeles, CA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
987
mi
from 98109
Santa Ana, CA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
987
mi
from 98109
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
2322
mi
from 98109
Washington,
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
2543
mi
from 98109
Bradenton, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
2543
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
2450
mi
from 98109
Gainesville, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
2450
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
2725
mi
from 98109
Hialeah, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
2725
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials